Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Microbiology"
DOI: 10.1007/s12275-018-8037-z
Abstract: Mucosal surfaces that line our gastrointestinal tract are continuously exposed to trillions of bacteria that form a symbiotic relationship and impact host health and disease. It is only beginning to be understood that the cross-talk… read more here.
Keywords: targeting friend; foe emerging; disease; therapeutics age ... See more keywords
The potential of emerging therapeutics for epithelioid sarcoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2017.1405805
Abstract: ABSTRACT Introduction: Epithelioid sarcoma (ES) is a rare malignancy of mesenchymal origin that accounts for read more here.
Keywords: therapeutics epithelioid; treatment; potential emerging; emerging therapeutics ... See more keywords
Advances in current and emerging therapeutics for gestational trophoblast malignancies
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2019.1559047
Abstract: ABSTRACT Introduction: Gestational Trophoblastic Neoplasia (GTN) are a group of rare malignancies arising from the cells of conception. GTN was the first metastatic cancer to be cured with chemotherapy and nearly all of today’s patients… read more here.
Keywords: advances current; current emerging; gestational trophoblast; therapeutics gestational ... See more keywords
Familial hypercholesterolaemia and emerging therapeutics
Sign Up to like & getrecommendations! Published in 2023 at "Heart"
DOI: 10.1136/heartjnl-2022-321917
Abstract: To cite: Farias FI, Kim SM, Shapiro MD. Heart Epub ahead of print: [please include Day Month Year]. doi:10.1136/ heartjnl-2022-321917 Department of Medicine, University of Washington Medical Center, Seattle, Washington, USA Cardiology, New YorkPresbyterian Weill… read more here.
Keywords: familial hypercholesterolaemia; cardiology; emerging therapeutics; hypercholesterolaemia emerging ... See more keywords
Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics.
Sign Up to like & getrecommendations! Published in 2019 at "Annual review of medicine"
DOI: 10.1146/annurev-med-041217-011106
Abstract: Postpartum depression (PPD) is common, disabling, and treatable. The strongest risk factor is a history of mood or anxiety disorder, especially having active symptoms during pregnancy. As PPD is one of the most common complications… read more here.
Keywords: treatment; postpartum depression; emerging therapeutics; depression pathophysiology ... See more keywords
Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.657768
Abstract: Autoimmune diseases affect roughly 5-10% of the total population, with women affected more than men. The standard treatment for autoimmune or autoinflammatory diseases had long been immunosuppressive agents until the advent of immunomodulatory biologic drugs,… read more here.
Keywords: tolerance; immune tolerance; autoimmune diseases; tolerogenic vaccines ... See more keywords
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Sign Up to like & getrecommendations! Published in 2019 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics11090441
Abstract: The built-in innate immunity in the human body combats various diseases and their causative agents. One of the components of this system is Toll-like receptors (TLRs), which recognize structurally conserved molecules derived from microbes and/or… read more here.
Keywords: toll like; receptors relevant; delivery; relevant emerging ... See more keywords
SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Delivery"
DOI: 10.4155/tde-2021-0075
Abstract: As SARS-CoV-2 emerge, variants such as Omicron (B.1.1.529), Delta (B.1.617.2), and those from the United Kingdom (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and India (B.1.6.17 lineage) have raised concerns of the reduced neutralising ability of… read more here.
Keywords: therapeutics challenges; challenges future; emerging therapeutics; cov vaccinology ... See more keywords